Your Daily Dose of South African News

Contact us
Search

Features

Features

Boy, 9, can no longer walk after being locked in dad's van for nearly 500 days

Apr 12, 2026
Features

Scenes of devastation after Israel bombs Lebanon 100 times in 10 minutes

Apr 9, 2026
Features

Bar staff laughed in face of machete robber thinking he was \u2018prankster neighbour\u2019

Apr 1, 2026
Recommend

Trump is turned into a Minion in new video after Iran doubles down in AI meme war

Apr 16, 2026

Facebook engineer 'designed programme to download 30,000 private images from UK accounts'

Apr 8, 2026

Scientists create world's fastest 'underwater supercar' - and it's only \u00a34,300,000

Mar 31, 2026

Atrend Ltd Launches Primary Market Accounts to Empower Members in Pre-Market Trading and IPO Subscription, Achieving Breakthroughs in Investment Learning and Returns

Aug 5, 2025

All News

Features

Akeso to Share Global Strategy for New Drug Development at the 43rd J.P. Morgan Healthcare Conference

HONG KONG and SAN FRANCISCO,Jan. 7,2025-- Akeso,Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce its participation in the upcoming 43rd Annual J.P. Morgan Healthcar

Jan 8, 2025
Features

HL Mando and HL Klemove Jointly Participate in CES 2025

HL Heroes Video Revealed with the Slogan "Envision the Future" Showcasing Innovations such as HAECHIE,BEETLE+,and AgriShield

Jan 8, 2025
Features

EarFun Unveils Advanced AI Translation and Dual-Unit Wireless Audio Technology

SANTA MONICA,Calif.,Jan. 7,2025-- EarFun,a global leader in wireless audio technology,is set to make waves atCES 2025 with the debut of an impressive lineup of innovative products. From reimagined ope

Jan 8, 2025
Features

Utility and GH EnA Sign Joint Project Development Agreement for the Korean Biogas to Hydrogen Mobility Market

Utility andGH EnA to implement H2Gen projects to produce clean carbon-negative hydrogen using biogas for Korea\'s growing low carbon mobility market

Jan 8, 2025
Features

GORTEC Announces New Trial Success for Head and Neck Cancer Treatment

TOURS,France,Jan. 7,2025-- GORTEC,known as Head and Neck Radiation Oncology Group,today announced that the randomized Phase 3 NIVOPOSTOP GORTEC 2018-01 trial evaluating nivolumab,Bristol Myers Squibb

Jan 8, 2025
Features

Mega Matrix Inc. Attended China-UAE Industry and Investment Cooperation Conference to Further Deepen Middle East Short Drama Strategy

SINGAPORE,Jan. 7,2025--Mega Matrix Inc. (NYSE American: MPU) announced that it attended the China (Shanghai)-UAE Industry and Investment Cooperation Conference,themed "Exploring Overseas Markets

Jan 8, 2025
1 ... 103 104 105 106 107 108 109 ... 130